Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 May 16;395(10236):1525-1527.
doi: 10.1016/S0140-6736(20)31023-0. Epub 2020 Apr 29.

Remdesivir for COVID-19: challenges of underpowered studies

John David Norrie  1
Affiliations
Comment

Remdesivir for COVID-19: challenges of underpowered studies

John David Norrie. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Wang Y, et al. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Lancet. 2020. PMID: 32423584 Free PMC article. Clinical Trial.

References

    1. Wang Y, Zhang D, Du G. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 doi: 10.1016/S0140-6736(20)31022-9. published online April 29. - DOI - PMC - PubMed
    1. WHO . World Health Organization; Geneva: Feb 18, 2020. COVID-19 therapeutic trial synopsis.https://www.who.int/blueprint/priority-diseases/key-action/COVID-19_Trea...
    1. Holshue ML, DeBolt C, Lindquist S. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382:929–936. - PMC - PubMed
    1. Grein J, Ohmagari N, Shin D. Compassionate use of remdesivir for patients with severe COVID-19. N Engl J Med. 2020 doi: 10.1056/NEJMoa2007016. published online April 10. - DOI - PMC - PubMed
    1. Ford I, Norrie J. Pragmatic Trials. N Engl J Med. 2016;375:454–463. - PubMed